CCI Photonics

CCI Photonics, established in June 2023 as a spin-out from Lancaster University, specializes in the rapid identification of infectious diseases, delivering results within 15 minutes. Operating from the Research and Enterprise Services at Lancaster University, the company focuses on developing medical instruments and conducting biotechnology research to address the limitations of traditional diagnostic methods, which often involve time-consuming processes and multiple microbiological techniques, leading to delays of 24 to 48 hours. By providing swift and accurate diagnostics, CCI Photonics aims to mitigate the risks associated with antimicrobial resistance, reducing patient morbidity and mortality. The company's innovative approach has attracted investment from programs like Praetura Ventures' PraeSeed, highlighting its potential to revolutionize infectious disease diagnostics.

Keywords: CCI Photonics, infectious disease diagnostics, rapid identification, medical instruments, biotechnology research, antimicrobial resistance, Lancaster University, Praetura Ventures, PraeSeed program, healthcare innovation.